Home PALI
4.24
  Price10.13%   +0.39
 
loading

Palisade Bio Inc (PALI) Latest News

Dec-01-22 02:44AM Palisade Bio Regains Compliance with Nasdaq Listing RequirementsGlobeNewswire Inc.
Nov-23-22 12:37PM Palisade Bio's (PALI) LB1148 Gets FDA Fast-Track DesignationZacks Investment Research
07:38AM Why Manchester United Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving PremarketBenzinga
Nov-23-22 06:00AM Should You Be Buying Penny Stocks? Here’s 3 Reasons WhyPennyStocks
05:25AM Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From YesterdayBenzinga
Nov-22-22 01:16AM Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day SessionBenzinga
12:40PM Crude Oil Surges 2%; Best Buy Posts Upbeat EarningsBenzinga
Nov-22-22 10:35AM US Stocks Open Higher As Dow Surges 250 PointsBenzinga
08:35AM Palisade Bio is Granted Fast Track Designation from the U.S. Food and Drug Administration for LB1148 for Accelerated Return of Bowel Function following GI SurgeryGlobeNewswire Inc.
Nov-18-22 08:05AM Palisade Bio Appoints Herbert B. Slade, MD, FAAAAI as Chief Medical OfficerGlobeNewswire Inc.
Nov-16-22 05:01AM Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From YesterdayBenzinga
Nov-15-22 11:15AM Palisade Bio Announces Reverse Stock SplitGlobeNewswire Inc.
Nov-14-22 08:45AM Palisade Bio Reports Third Quarter 2022 Financial Results and Provides Business UpdateGlobeNewswire Inc.
Oct-11-22 09:25AM Palisade Bio Announces Executive Leadership TransitionGlobeNewswire Inc.
Oct-05-22 06:54AM Why Vicinity Motor Is Trading Higher By Over 65%; Here Are 26 Stocks Moving PremarketBenzinga
Sep-29-22 08:35AM Palisade Bio Announces Oral Presentation of Phase 2 Data at the American College of Surgeons (ACS) Clinical Congress 2022GlobeNewswire Inc.
Sep-23-22 04:30AM Palisade Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire Inc.
Sep-21-22 09:23AM Palisade Bio to Present at the Ladenburg Thalmann 2022 Healthcare ConferenceGlobeNewswire Inc.
Sep-14-22 03:58AM Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From YesterdayBenzinga
Sep-13-22 09:05AM Palisade Bio to Present at the Virtual Investor Innovations in Intestinal Health - Launching a Pivotal Phase 3 Study for Return of Postoperative Bowel Function EventGlobeNewswire Inc.
Aug-25-22 12:00PM Palisade Bio, Inc. (PALI) Moves to Buy: Rationale Behind the UpgradeZacks Investment Research
11:51AM Top Penny Stocks To Buy? 4 For Your Watch List Before Next WeekPennyStocks
Aug-19-22 10:52AM Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2022Benzinga
06:00AM Hot Penny Stocks to Add to Your Watchlist Right Now PennyStocks
Aug-18-22 07:23AM This Healthcare Stock Is Trading Lower By 29%: Here Are 29 Stocks Moving PremarketBenzinga
06:00AM Cheap Penny Stocks to Buy Now? 3 To Watch in AugustPennyStocks
Aug-18-22 04:59AM This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From YesterdayBenzinga
Aug-17-22 12:03PM Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day SessionBenzinga
08:35AM Palisade Bio Announces First Patient Enrolled and Dosed in Pivotal Phase 3 Study Evaluating LB1148 for Postoperative Return of Bowel FunctionGlobeNewswire Inc.
Aug-16-22 04:05AM Palisade Bio Announces Closing of $13.8 Million Upsized Underwritten Public Offering and Full Exercise of Over-Allotment OptionGlobeNewswire Inc.
Aug-15-22 03:43AM Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From FridayBenzinga
Aug-12-22 12:54PM Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day SessionBenzinga
06:23AM Why Is Toast Trading Higher By 20%: Here Are 34 Stocks Moving PremarketBenzinga
Aug-11-22 07:17AM Why Is Disney Higher By More Than 7%: Here Are 40 Stocks Moving PremarketBenzinga
Aug-10-22 03:52AM Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From YesterdayBenzinga
Jun-07-22 08:30AM Palisade Bio to Present at the 2022 BIO International ConventionGlobeNewswire Inc.
Palisade Bio, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor intended to inhibit digestive enzyme activity and preserve gut integrity during intestinal stress, such as results from reduced blood flow to the intestine, infections, and surgery. The company was founded in 2005 and is based in Carlsbad, California.
Cap:    |  Volume (24h):